Publication | Open Access
Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study
17
Citations
22
References
2022
Year
Our study reveals important heterogeneity in the use of asthma biologics across Europe. To what extent this impacts on clinical outcomes relevant to patients and healthcare services needs further investigation.
| Year | Citations | |
|---|---|---|
Page 1
Page 1